Compare Alibaba Group (BABA) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alibaba Group vs Smith & Nephew plc — how do they compare? Alibaba Group trades at $124.21 (market cap $308.93B), while Smith & Nephew plc trades at $29.55 (market cap $12.54B). The key difference: Alibaba Group is far larger — about 24.6× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.65%). Which is the better fit depends on your goals.
| BABA | SNN | |
|---|---|---|
Market Cap | $308.93B | $12.54B |
Volume | 18,069,938 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $189.34 | $38.70 |
52-Week Low | $94.83 | $28.73 |
Enterprise Value | $303.72B | $15.57B |
Dividend Yield | 0.82% | 2.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BABA trades at $132.32, up 3.04% today, with a bullish technical signal from moving averages but bearish oscillators. The company reported strong 2025 results with $996.35B revenue and $130.11B net income, though recent quarterly EPS misses raise concerns. Analyst consensus remains strongly bullish with an $195.00 price target, but multiple class action lawsuits filed in August 2026 create significant legal overhang.
BABA presents a mixed investment case with strong fundamentals and Wall Street support offset by legal risks and earnings volatility. The stock trades at reasonable valuations (P/E 19.61, P/S 2.03) with solid profitability metrics, but investors must weigh the substantial legal challenges against the company's operational strength and growth trajectory.
Smith & Nephew (SNN) trades at $30.08, down 0.1% with bearish technical signals. The company reported mixed Q2 2026 results with revenue growth below expectations, leading to a reduced full-year outlook. Fundamentals show strong profitability with 10.1% net margin and improving cash flow trends, though recent earnings misses have tempered sentiment.
Outlook remains cautious with analyst consensus at Hold (65% of coverage). Near-term risks include U.S. orthopedics weakness and competitive pressures, offset by robotics innovation and value-based care expansion. The stock offers stable fundamentals but faces execution challenges in key markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alibaba Group
Alibaba Group Holding Limited operates as a holding company. The Company provides internet infrastructure, electronic commerce, online financial, and internet content services through its subsidiaries. Alibaba Group Holding offers its products and services worldwide.
Read more on BABA →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
